Details
Original language | English |
---|---|
Pages (from-to) | 250-262 |
Number of pages | 13 |
Journal | Acta biomaterialia |
Volume | 73 |
Early online date | 19 Apr 2018 |
Publication status | Published - Jun 2018 |
Externally published | Yes |
Abstract
In this work, we define the requirements for a human cell-based osteomyelitis model which overcomes the limitations of state of the art animal models. Osteomyelitis is a severe and difficult to treat infection of the bone that develops rapidly, making it difficult to study in humans. We have developed a 3D in vitro model of the bone marrow, comprising a macroporous material, human hematopoietic stem and progenitor cells (HSPCs) and mesenchymal stromal cells (MSCs). Inclusion of biofilms grown on an implant into the model system allowed us to study the effects of postoperative osteomyelitis-inducing bacteria on the bone marrow. The bacteria influenced the myeloid differentiation of HSPCs as well as MSC cytokine expression and the MSC ability to support HSPC maintenance. In conclusion, we provide a new 3D in vitro model which meets all the requirements for investigating the impact of osteomyelitis. Statement of Significance: Implant-associated osteomyelitis is a persistent bacterial infection of the bone which occurs in many implant patients and can result in functional impairments or even entire loss of the extremity. Nevertheless, surprisingly little is known on the triangle interaction between implant material, bacterial biofilm and affected bone tissue. Closing this gap of knowledge would be crucial for the fundamental understanding of the disease and the development of novel treatment strategies. For this purpose, we developed the first biomaterial-based system that is able to mimic implant-associated osteomyelitis outside of the body, thus, opening the avenue to study this fatal disease in the laboratory.
Keywords
- 3D in vitro model, Biofilm, Bone marrow analog, Osteomyelitis
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)
- Biotechnology
- Materials Science(all)
- Biomaterials
- Biochemistry, Genetics and Molecular Biology(all)
- Biochemistry
- Engineering(all)
- Biomedical Engineering
- Biochemistry, Genetics and Molecular Biology(all)
- Molecular Biology
Sustainable Development Goals
Cite this
- Standard
- Harvard
- Apa
- Vancouver
- BibTeX
- RIS
In: Acta biomaterialia, Vol. 73, 06.2018, p. 250-262.
Research output: Contribution to journal › Article › Research › peer review
}
TY - JOUR
T1 - Biomimetic 3D in vitro model of biofilm triggered osteomyelitis for investigating hematopoiesis during bone marrow infections
AU - Raic, Annamarija
AU - Riedel, Sophie
AU - Kemmling, Elena
AU - Bieback, Karen
AU - Overhage, Joerg
AU - Lee-Thedieck, Cornelia
N1 - Funding information: The project was supported by contract research ‘Bioinspirierte Materialsynthese’ of the Baden-Württemberg Foundation (BioMatS-14) and by the young investigator network (YIN) of the KIT . The authors declare no conflict of interests. The macroporous scaffold and its usage for cell cultivation is registered for patent approval ( DE102017006372.6 ). The project was supported by contract research ?Bioinspirierte Materialsynthese? of the Baden-W?rttemberg Foundation (BioMatS-14) and by the young investigator network (YIN) of the KIT. The authors declare no conflict of interests. The macroporous scaffold and its usage for cell cultivation is registered for patent approval (DE102017006372.6).
PY - 2018/6
Y1 - 2018/6
N2 - In this work, we define the requirements for a human cell-based osteomyelitis model which overcomes the limitations of state of the art animal models. Osteomyelitis is a severe and difficult to treat infection of the bone that develops rapidly, making it difficult to study in humans. We have developed a 3D in vitro model of the bone marrow, comprising a macroporous material, human hematopoietic stem and progenitor cells (HSPCs) and mesenchymal stromal cells (MSCs). Inclusion of biofilms grown on an implant into the model system allowed us to study the effects of postoperative osteomyelitis-inducing bacteria on the bone marrow. The bacteria influenced the myeloid differentiation of HSPCs as well as MSC cytokine expression and the MSC ability to support HSPC maintenance. In conclusion, we provide a new 3D in vitro model which meets all the requirements for investigating the impact of osteomyelitis. Statement of Significance: Implant-associated osteomyelitis is a persistent bacterial infection of the bone which occurs in many implant patients and can result in functional impairments or even entire loss of the extremity. Nevertheless, surprisingly little is known on the triangle interaction between implant material, bacterial biofilm and affected bone tissue. Closing this gap of knowledge would be crucial for the fundamental understanding of the disease and the development of novel treatment strategies. For this purpose, we developed the first biomaterial-based system that is able to mimic implant-associated osteomyelitis outside of the body, thus, opening the avenue to study this fatal disease in the laboratory.
AB - In this work, we define the requirements for a human cell-based osteomyelitis model which overcomes the limitations of state of the art animal models. Osteomyelitis is a severe and difficult to treat infection of the bone that develops rapidly, making it difficult to study in humans. We have developed a 3D in vitro model of the bone marrow, comprising a macroporous material, human hematopoietic stem and progenitor cells (HSPCs) and mesenchymal stromal cells (MSCs). Inclusion of biofilms grown on an implant into the model system allowed us to study the effects of postoperative osteomyelitis-inducing bacteria on the bone marrow. The bacteria influenced the myeloid differentiation of HSPCs as well as MSC cytokine expression and the MSC ability to support HSPC maintenance. In conclusion, we provide a new 3D in vitro model which meets all the requirements for investigating the impact of osteomyelitis. Statement of Significance: Implant-associated osteomyelitis is a persistent bacterial infection of the bone which occurs in many implant patients and can result in functional impairments or even entire loss of the extremity. Nevertheless, surprisingly little is known on the triangle interaction between implant material, bacterial biofilm and affected bone tissue. Closing this gap of knowledge would be crucial for the fundamental understanding of the disease and the development of novel treatment strategies. For this purpose, we developed the first biomaterial-based system that is able to mimic implant-associated osteomyelitis outside of the body, thus, opening the avenue to study this fatal disease in the laboratory.
KW - 3D in vitro model
KW - Biofilm
KW - Bone marrow analog
KW - Osteomyelitis
UR - http://www.scopus.com/inward/record.url?scp=85046764757&partnerID=8YFLogxK
U2 - 10.1016/j.actbio.2018.04.024
DO - 10.1016/j.actbio.2018.04.024
M3 - Article
VL - 73
SP - 250
EP - 262
JO - Acta biomaterialia
JF - Acta biomaterialia
SN - 1742-7061
ER -